非诺贝特通过上调短链酰基辅酶A脱氢酶抑制大鼠心肌肥厚

中国临床药理学与治疗学 ›› 2013, Vol. 18 ›› Issue (8): 868-873.

非诺贝特通过上调短链酰基辅酶A脱氢酶抑制大鼠心肌肥厚

周四桂¹, 徐立朋², 路遥³, 袁茜³, 潘雪刁¹, 臧林泉¹

¹广东药学院临床药学系,广州 510006,广东;
²暨南大学药学院新药研究所,广州 510632,广东;
³中山大学中山医学院临床医学八年制2007级,广州 510080,广东

收稿日期:2013-02-04 修回日期:2013-06-26 出版日期:2013-08-26 发布日期:2013-07-31
通讯作者: 徐立朋,男,博士,副教授,研究方向:心血管药理学。Tel: 020-38375027 E-mail: xulipeng2000@163.com
作者简介:周四桂,女,博士,副教授,研究方向:心血管药理学。Tel: 020-39352123 E-mail: susanzsg@163.com
基金资助:
国家自然科学基金青年科学基金资助项目(81000072, 81001683);教育部留学回国启动基金资助项目(23610008);教育部博士学科点专项科研基金资助项目(20104401120003)

Fenofibrate inhibits cardiac hypertrophy by up-regulation of short-chain acyl-CoA dehydrogenase

ZHOU Si-gui¹, XU Li-peng², LU Yao³, YUAN Xi³, PAN Xue-diao¹, ZANG Lin-quan¹

¹Department of Clinical Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, Guangdong, China;
²Institute of New Drug Research, Jinan University College of Pharmacy, Guangzhou 510632, Guangdong, China;
³Clinical Medicine Eight Years 1st Class 2007 Grade, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, Guangdong, China

Received:2013-02-04 Revised:2013-06-26 Online:2013-08-26 Published:2013-07-31

摘要/Abstract

摘要： 目的: 研究非诺贝特对自发性高血压大鼠(Spontaneously hypertensive rats, SHR)心肌中短链酰基辅酶A脱氢酶(Short-chain acyl-CoA dehydrogenase, SCAD)的表达、心肌脂质代谢变化以及心肌肥厚指标的影响,探讨非诺贝特改善SHR心肌肥厚的作用机制。方法: 观察非诺贝特灌胃8周后,SHR的血压及左室重量指数、血清和心肌游离脂肪酸含量的变化,采用Western blot方法检测心肌过氧化物酶体增殖剂活化受体α(PPARα)和SCAD的蛋白表达变化,采用厌氧性电子转移黄素蛋白荧光还原分析法检测SCAD酶活性的改变。结果: 与Wistar-Kyoto(WKY)大鼠比较,SHR的血压及左室重量指数均明显增高,心肌中PPARα与SCAD的蛋白表达明显下调,SCAD的酶活性显著降低,血清和心肌游离脂肪酸含量增加(P<0.05);与SHR比较,非诺贝特治疗8周后的SHR,其左室重量指数明显下降,血压无明显变化,心肌中PPARα与SCAD的蛋白表达明显上调,SCAD的酶活性显著增高,血清和心肌游离脂肪酸含量减少(P<0.05)。结论: 非诺贝特增加心肌中SCAD的蛋白表达,改善心肌能量代谢障碍, 可能是其抑制心肌肥厚发生与发展的机制之一。

关键词: 非诺贝特, 心肌肥厚, 过氧化物酶体增殖物激活受体α, 短链酰基辅酶A脱氢酶, 脂肪酸氧化

Abstract: AIM: To investigate the effect of fenofibrate on the expression of short-chain acyl-CoA dehydrogenase (SCAD), cardiac lipid metabolism and cardiac hypertrophy in spontaneously hypertensive rats (SHR).METHODS: SHR were given fenofibrate for 8 weeks, then systolic pressure and the ratios of left ventricular weight to body weight, free fatty acid in blood serum and cardiac muscle were measured. The expression of PPARα and SCAD in myocardium were investigated by western blot. Enzyme activity of SCAD in myocardium was measured with the anaerobic electron transfer flavoprotein fluorescence reduction assay.RESULTS: Compared with WKY rats, systolic blood pressure and the ratios of left ventricular weight to body weight were markedly elevated in SHR. The expression of PPARα and SCAD in myocardium of SHR were decreased as compared with WKY group. The activity of SCAD in myocardium was lower than that in WKY rats. Free fatty acid in blood serum and cardiac muscle were higher than that in WKY rats. Compared with SHR, fenofibrate decreased the ratios of left ventricular weight to body weight, but had no effect on systolic blood pressure. After treated with fenofibrate, the expression of PPARα and SCAD in myocardium of SHR was increased in associated with lower contents of free fatty acid in blood serum and cardiac muscle.CONCLUSION: Fenofibrate may ameliorate cardiac hypertrophy by increasing the expression of SCAD and improving cardiac energy metabolism in SHR.

Key words: Fenofibrate, Cardiac hypertrophy, Peroxisome proliferators activated receptor, Short-chain acyl-CoA dehydrogenase, Fatty acid oxidation

中图分类号:

R965.2

周四桂, 徐立朋, 路遥, 袁茜, 潘雪刁, 臧林泉. 非诺贝特通过上调短链酰基辅酶A脱氢酶抑制大鼠心肌肥厚[J]. 中国临床药理学与治疗学, 2013, 18(8): 868-873.

ZHOU Si-gui, XU Li-peng, LU Yao, YUAN Xi, PAN Xue-diao, ZANG Lin-quan. Fenofibrate inhibits cardiac hypertrophy by up-regulation of short-chain acyl-CoA dehydrogenase[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(8): 868-873.

参考文献

[1] Pena L, Angle B, Burton B, et al. Follow-up of patients with short-chain acyl-CoA dehydrogenase and isobutyryl-CoA dehydrogenase deficiencies identified through newborn screening: one center's experience[J]. Genet Med, 2012, 14(3): 342-347.
[2] Zhou SG, Zhou SF, Huang HQ, et al. Proteomic analysis of hypertrophied myocardial protein patterns in renovascularly hypertensive and spontaneously hypertensive rats[J]. J Proteome Res, 2006, 5(11): 2901-2908.
[3] Smeets PJ, Teunissen BE, Willemsen PH, et al. Cardiac hypertrophy is enhanced in PPAR alpha-/- mice in response to chronic pressure overload[J]. Cardiovasc Res, 2008, 78(1): 79-89.
[4] Barger PM, Brandt JM, Leone TC, et al. Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth[J]. J Clin Invest, 2000, 105(12): 1723-1730.
[5] 李文举, 石苗茜, 欧东波, 等. 非诺贝特抑制血管紧张素II所诱导的心脏成纤维细胞骨桥蛋白表达升高[J]. 中国临床药理学与治疗学, 2010, 15(11): 1211-1215.
[6] Watanabe K, Fujii H, Takahashi T, et al. Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity[J]. J Biol Chem, 2000, 275(29): 22293-22299.
[7] Goetzman ES. The regulation of acyl-CoA dehydrogenases in adipose tissue by rosiglitazone[J]. Obesity, 2009, 17(1): 196-198.
[8] Frerman FE, Goodman SI. Fluorometric assay of acyl-CoA dehydrogenases in normal and mutant human fibroblasts[J]. Biochem Med, 1985, 33(1): 38-44.
[9] Kolwicz SC Jr, Tian R. Glucose metabolism and cardiac hypertrophy[J]. Cardiovasc Res, 2011, 90(2): 194-201.
[10] 高杉, 黄春霞, 黄玲玲, 等. 低聚葡萄籽原花青素对异丙肾上腺素诱导心肌细胞肥大的影响[J]. 中国临床药理学与治疗学, 2012, 17(5): 497-501.
[11] 于妍, 王硕仁, 聂波, 等. 川芎嗪、缬沙坦及曲美他嗪对乳鼠肥大心肌细胞线粒体结构和能量代谢的影响[J]. 中西医结合心脑血管病杂志, 2012, 10(3): 321-324.
[12] 周四桂, 王平, 路遥, 等. 短链酰基辅酶A脱氢酶在大鼠心脏发育中的表达及其与心肌肥厚关系的研究[J].中国病理生理杂志,2013, 29(1): 9-14.
[13] 周四桂, 王平, 路遥, 等. 短链酰基辅酶A 脱氢酶在大鼠生理性和病理性心肌肥大中的作用[J]. 中国病理生理杂志, 2012, 28(11): 1921-1927.
[14] 师凌云, 田蜜, 常伟, 等. 小檗碱对脂质代谢相关基因PPARα和CPTIA表达的影响[J]. 中国药理学通报, 2008, 24(11): 1461-1464.
[15] 陈红娟, 陈君柱, 王兴祥, 等. PPARα激动剂菲诺贝特改善自发性高血压大鼠左室肥厚及PPARα表达[J]. 浙江大学学报:医学版, 2007, 36(5): 470-476.